Skip to content
iStock-1500823492 (1) iStock-1500823492 (1)

Streamline Your Study Start Up with Precision

Kickstart your clinical trials with efficiency and expertise.
In today’s fast-paced clinical trial environment, initiating your study effectively is more critical than ever. Precision's approach to Study Start Up combines technological innovation, regulatory insight, and global expertise to optimize every phase of trial initiation, ensuring your study begins with the momentum needed to succeed.
iStock-1332002332 (1) (1)

Accelerating your clinical trial start up

Successful clinical trials begin with a well-executed study start up. By focusing on strategic site selection and swift regulatory submissions,  Precision’s global study start up team helps set the foundation for timely and successful trial outcomes. Our team delivers site activation with precision by leveraging locally dedicated staff and through close partnership with our Regulatory Affairs department. Through this synergy, we streamline submissions across North America, Europe, and Asia Pacific. Every study presents its own unique challenges therefore it's critical to work with seasoned staff dedicated to guiding effective study start up.
5 Average years of start up experience
45 countries supported by Precision’s Start Up team

Our Proven Pathway to Study Start Up Success

Precision's study start up services are built on a foundation of detailed planning and proactive strategy. From identifying the most suitable sites worldwide to navigating the complexities of local and global regulations, our team ensures your study is initiated without delay. With a focus on cross-functional collaboration, accountability, and proactive risk management, we partner with you to accelerate patients' access to life-changing therapies.
The Precision path

Expert perspectives from Precision

Gain new insights and strategies from our experts at the forefront of clinical and translational research.

Read: Progress in Gastrointestinal Oncology: 5 Key Insights from ASCO GI Progress in Gastrointestinal Oncology: 5 Key Insights from ASCO GI

Progress in Gastrointestinal Oncology: 5 Key Insights from ASCO GI

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=178509987433, hs_child_table_id=0, hs_updated_at=1728330014032, hs_published_at=1739807653319, description=Ivan Barrera, MD is a fellowship-trained expert in Research GI Oncology with over 15 years of clinical research experience across various healthcare systems and facilities. He is a methodical and strategic key player in interdisciplinary drug development teams, specializing in medical monitoring. Dr. Barrera has extensive experience in solid tumors, particularly Gastrointestinal Oncology, including Neuroendocrine Tumors, and has worked on FIH and Phase I-IV studies. His industry clinical development experience spans small molecules, antibodies, vaccines, cytokines, oncolytic viruses, radiopharmaceuticals, and cellular therapies., avatar=Image{width=685,height=649,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Ivan%20Barrera.jpg',altText='Ivan Barrera',fileId=180445483936}, lastname=Barrera, hs_initial_published_at=1726512636738, hs_created_by_user_id=26433386, hs_created_at=1726500269983, hs_is_edited=false, hs_deleted_at=0, name=Ivan, job=Senior Medical Director, slug=ivan-barrera, hs_updated_by_user_id=26433386}, second={}, third={}})
  • Ivan Barrera avatar

    Ivan Barrera

Discover
Read: Case Study Phase 3 NSCLC: Site Relationships Streamline Feasibility Case Study Phase 3 NSCLC: Site Relationships Streamline Feasibility

Clinical Trials

Case Study Phase 3 NSCLC: Site Relationships Streamline Feasibility

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=185838258545, hs_child_table_id=0, hs_updated_at=1738849388884, hs_published_at=1739807653319, description=Anna Rodecki is a results driven leader with 24 years of experience in clinical research across the pharmaceutical, device, and biotech industries. She has played a pivotal role in shaping clinical development plans on both Sponsor and CRO, successfully supporting First- In-Human (FIH) – Phase IV trials successfully across various therapeutics areas. Anan thrives on building strong, collaborative teams fostering innovation. Her expertise spans strategic planning, risk management, inspection readiness and cross-functional leadership – always with a focus on improving patient outcomes and advancing the future of medicine., avatar=Image{width=1200,height=1200,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Anna%20Rodecki.png',altText='Anna Rodecki',fileId=185842773784}, lastname=Rodecki, hs_initial_published_at=1738849393727, hs_created_by_user_id=26433386, hs_created_at=1738849349748, hs_is_edited=false, hs_deleted_at=0, name=Anna, job=Director, Project Management, slug=anna-rodecki, hs_updated_by_user_id=26433386}, second={}, third={}})
  • Anna Rodecki avatar

    Anna Rodecki

Discover
Read: Source Data Verification Types, Trends, and Tips Source Data Verification Types, Trends, and Tips

Clinical Trials

Source Data Verification Types, Trends, and Tips

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=183222587782, hs_child_table_id=0, hs_updated_at=1732630460690, hs_published_at=1739807653319, description=Jelena Alexander brings 18 years of industry experience across the CRO, biotech and R&D arenas, with the last eight years focused on clinical operations oversight and aligning resources with project needs. Prior to transitioning to clinical research, Jelena obtained a Master’s degree in infectious disease and immunology, specializing in the development of cross-reactive and neutralizing monoclonal antibodies to foot-and-moth disease virus. Jelena is a collaborative leader recognized for fostering relationships with stakeholders to embed sustainable workflow processes and for delivering high quality outputs to ensure business needs are accomplished on time and within budget. Jelena’s expertise extends to evaluating and assessing clinical proposals, with a focus on monitoring strategies, and operational feasibility. In this role, Jelena leverages operational and leadership expertise to deliver high-quality, client-focused solutions while enhancing efficiency and sustainability in proposal strategies. Jelena is devoted to driving innovation, mentoring teams, and achieving results through adaptability and commitment to quality., avatar=Image{width=800,height=800,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Jelena%20Alexander.jpg',altText='Jelena Alexander',fileId=183228271491}, lastname=Alexander, hs_initial_published_at=1732630470588, hs_created_by_user_id=26433386, hs_created_at=1732630317363, hs_is_edited=false, hs_deleted_at=0, name=Jelena, job=Senior Manager, Global Clinical Monitoring, slug=jelena-alexander, hs_updated_by_user_id=26433386}, second={}, third={}})
  • Jelena Alexander avatar

    Jelena Alexander

Discover
  • Discover Early Phase Excellence
    82 (1)

    Early Phase Excellence

    Embark on the critical first steps of clinical discovery with our expertly managed early phase trials, where meticulous attention meets innovative strategy

    Explore
  • Discover Late Phase Success
    late-phase

    Late Phase Success

    Discover the path to market with our Late Phase Development expertise – delivering precision, scale, and efficiency for your clinical journey.

    Explore

Deep experience with debilitating disease and unique modalities

Like you, we understand that there’s a patient throughout the development pathway. Supporting our partners to bring innovative treatments to patients is our purpose. Leverage our experience in these therapeutic areas.

Specialized capabilities in every stage of clinical development

Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to increase speed to market. Incorporate manufacturing expertise for advances therapies to ensure scalability. Precision can customize and converge our capabilities for your program's unique needs.

  • Discover Explore
    clinical-trial-support

    Global CRO
    Services

    Award-winning CRO with deep oncology and rare disease expertise

    Explore
  • Discover Explore
    specialty-lab-services

    Global Laboratory
    Services

    Exceptional translational and biomarker sciences with global central lab services

    Explore
  • Discover Explore
    Manufacturing

    Manufacturing
    Solutions

    Pioneers in planning, building and maintaining manufacturing at scale for pharma and biotechs.

    Explore